This brand name is authorized in Hong Kong SAR China, Japan, Spain, Turkey.
The drug MEIACT contains one active pharmaceutical ingredient (API):
1
|
UNII
78THA212DH - CEFDITOREN PIVOXIL
|
|
Cefditoren is a cephalosporin with antibacterial activity against gram-positive and gram-negative pathogens. The bactericidal activity of cefditoren results from the inhibition of cell wall synthesis via affinity for penicillin-binding proteins (PBPs). |
|
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC Group | Classification | |
|---|---|---|
| J01DD16 | Cefditoren | J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01D Other beta-lactam antibacterials → J01DD Third-generation cephalosporins |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| ES | Centro de información online de medicamentos de la AEMPS | 65943, 65975 |
| HK | Department of Health Drug Office | 59773 |
| JP | 医薬品医療機器総合機構 | 6132015C1103, 6132015F1037 |
| TR | İlaç ve Tıbbi Cihaz Kurumu | 8699772091389, 8699772091396, 8699772091426 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.